Telehealth Made EASY: Understanding Provider Perceptions of Telehealth Appropriateness in Outpatient Rheumatology Encounters.
Date
2022-07-19
Journal Title
Journal ISSN
Volume Title
Citation Stats
Abstract
Objective
The purpose of this study was to evaluate a novel scoring system, the Encounter Appropriateness Score for You (EASY), to assess provider perceptions of telehealth appropriateness in rheumatology encounters.Methods
The EASY scoring system prompts providers to rate their own encounters as follows: in-person or telehealth acceptable, EASY = 1; in-person preferred, EASY = 2; or telehealth preferred, EASY = 3. Assessment of the EASY scoring system occurred at a single academic institution from January 1, 2021, to August 31, 2021. Data were collected in three rounds: 1) initial survey (31 providers) assessing EASY responsiveness to five hypothetical scenarios, 2) follow-up survey (34 providers) exploring EASY responsiveness to 11 scenario modifications, and 3) assessment of EASYs documented in clinic care.Results
The initial and follow-up surveys demonstrated responsiveness of EASYs to different clinical and nonclinical factors. For instance, less than 20% of providers accepted telehealth when starting a biologic for active rheumatoid arthritis, although more than 35% accepted telehealth in the same scenario if the patient lived far away or was well known to the provider. Regarding EASY documentation, 27 providers provided EASYs for 12,381 encounters. According to these scores, telehealth was acceptable or preferred for 29.7% of all encounters, including 21.4% of in-person encounters. Conversely, 24.4% of telehealth encounters were scored as in-person preferred.Conclusion
EASY is simple, understandable, and responsive to changes in the clinical scenario. We have successfully accumulated 12,381 EASYs that can be studied in future work to better understand telehealth utility and optimize telehealth triage.Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Smith, Isaac D, Theresa M Coles, Catherine Howe, Robert Overton, Nicoleta Economou-Zavlanos, Mary J Solomon, Rong Zhao, Bhargav Adagarla, et al. (2022). Telehealth Made EASY: Understanding Provider Perceptions of Telehealth Appropriateness in Outpatient Rheumatology Encounters. ACR open rheumatology. 10.1002/acr2.11470 Retrieved from https://hdl.handle.net/10161/25618.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Isaac David Smith
Theresa Marie Coles
Theresa Coles, Ph.D., is a health outcomes methodologist with a focus on measuring and evaluating patient-reported outcomes (PROs) and other clinical outcomes assessments (COAs), integrating PRO measures in clinical care, and improving interpretation of patient-centered outcome scores for use in healthcare delivery and clinical research settings to inform decision making.
My research program is comprised of 3 pillars:
- Enhance the assessment of physical function and related concepts to inform decision-making
- Improve interpretability of PRO scores
- Design and implement screeners to improve patient-centered care by measuring what matters
Nicoleta Economou-Zavlanos
Director of Duke Health AI Evaluation and Governance
Founding Director of Algorithm-Based Clinical Decision Support (ABCDS) Oversight
Nicoleta Economou-Zavlanos, PhD, is the Director of the Duke Health AI Evaluation & Governance Program and the founding director of the Algorithm-Based Clinical Decision Support (ABCDS) Oversight initiative. In this capacity, she leads Duke Health’s efforts to evaluate and govern health AI technologies. Dr. Economou also serves on the Executive Committee of the NIH Common Fund’s Bridge to Artificial Intelligence (Bridge2AI) Program and as a Scientific Advisor for the Coalition for Health AI (CHAI), driving the development of guidelines for AI assurance in healthcare.
A nationally recognized expert in health AI governance, Dr. Economou has been instrumental in creating frameworks and methodologies for the registration, review, and assurance of health AI systems. Her research, published in leading journals such as NPJ Digital Medicine, JAMA, JAMA Health Forum, and JAMIA, reflects her commitment to advancing the responsible development and use of AI in healthcare.
Megan Elizabeth Bowles Clowse
Dr. Megan Clowse is an Associate Professor of Medicine and Chief of the Division of Rheumatology and Immunology; she also holds joint appointments in the Department of Obstetrics and Gynecology and Population Health Sciences. Her clinical research focuses on the management of rheumatic diseases in pregnancy. She has cared for over 1000 pregnancies in women with rheumatic disease, collecting information on these pregnancies initially in the Duke Autoimmunity in Pregnancy Registry and Repository, and the MADRA (Maternal Autoimmune Disease Research Alliance) registry and repository. She served on the Core Leadership Team for the inaugural American College of Rheumatology's Reproductive Health Guidelines, published January 2020. Dr. Clowse created www.LupusPregnancy.org and www.ReproRheum.Duke.edu, websites dedicated to improving pregnancy planning and management for patients and rheumatologists.
Dr. Clowse was the founding director of the Duke Lupus Clinic, where she continues to see patients each week and mentor junior faculty researchers. The team has developed a new approach to lupus classification and management and is currently collecting and analyzing patient- and physician-reported measures to better clarify this construct.
David Leverenz
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.